These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 36097251)

  • 1. A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.
    Pouyan N; Halvaei Khankahdani Z; Younesi Sisi F; Lee Y; Rosenblat JD; Teopiz KM; Lui LMW; Subramaniapillai M; Lin K; Nasri F; Rodrigues N; Gill H; Lipsitz O; Cao B; Ho R; Castle D; McIntyre RS
    CNS Drugs; 2022 Oct; 36(10):1031-1047. PubMed ID: 36097251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
    Pouyan N; Younesi Sisi F; Kargar A; Scheidegger M; McIntyre RS; Morrow JD
    CNS Drugs; 2023 Dec; 37(12):1027-1063. PubMed ID: 37999867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.
    Kelly JR; Gillan CM; Prenderville J; Kelly C; Harkin A; Clarke G; O'Keane V
    Front Psychiatry; 2021; 12():800072. PubMed ID: 34975593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NIMH Research Domain Criteria (RDoC) Initiative and Its Implications for Research on Personality Disorder.
    Koudys JW; Traynor JM; Rodrigo AH; Carcone D; Ruocco AC
    Curr Psychiatry Rep; 2019 Apr; 21(6):37. PubMed ID: 31030293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-report indicators of negative valence constructs within the research domain criteria (RDoC): A critical review.
    Watson D; Stanton K; Clark LA
    J Affect Disord; 2017 Jul; 216():58-69. PubMed ID: 27823854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping Research Domain Criteria using a transdiagnostic mini-RDoC assessment in mental disorders: a confirmatory factor analysis.
    Förstner BR; Tschorn M; Reinoso-Schiller N; Maričić LM; Röcher E; Kalman JL; Stroth S; Mayer AV; Schwarz K; Kaiser A; Pfennig A; Manook A; Ising M; Heinig I; Pittig A; Heinz A; Mathiak K; Schulze TG; Schneider F; Kamp-Becker I; Meyer-Lindenberg A; Padberg F; Banaschewski T; Bauer M; Rupprecht R; Wittchen HU; Rapp MA
    Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):527-539. PubMed ID: 35778521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six Years of Research on the National Institute of Mental Health's Research Domain Criteria (RDoC) Initiative: A Systematic Review.
    Carcone D; Ruocco AC
    Front Cell Neurosci; 2017; 11():46. PubMed ID: 28316565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.
    Magaraggia I; Kuiperes Z; Schreiber R
    Neurobiol Learn Mem; 2021 Sep; 183():107467. PubMed ID: 34048913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Research Domain Criteria (RDoC) framework to eating disorders: emerging concepts and research.
    Wildes JE; Marcus MD
    Curr Psychiatry Rep; 2015 May; 17(5):30. PubMed ID: 25773226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood and anxiety disorders within the Research Domain Criteria framework of Positive and Negative Valence Systems: a scoping review.
    Böttger SJ; Förstner BR; Szalek L; Koller-Schlaud K; Rapp MA; Tschorn M
    Front Hum Neurosci; 2023; 17():1184978. PubMed ID: 37333832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.
    Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL
    Psychol Med; 2020 Dec; 50(16):2655-2666. PubMed ID: 33143790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Applications of the National Institute of Mental Health's Research Domain Criteria (RDoC) to Clinical Psychiatric Practice: How RDoC Might Be Used in Assessment, Diagnostic Processes, Case Formulation, Treatment Planning, and Clinical Notes.
    Yager J; Feinstein RE
    J Clin Psychiatry; 2017 Apr; 78(4):423-432. PubMed ID: 28002661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.
    Gill H; Puramat P; Patel P; Gill B; Marks CA; Rodrigues NB; Castle D; Cha DS; Mansur RB; Rosenblat JD; McIntyre RS
    Psychiatry Res; 2022 Jul; 313():114577. PubMed ID: 35580433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.
    Meccia J; Lopez J; Bagot RC
    Psychopharmacology (Berl); 2023 Jan; 240(1):27-40. PubMed ID: 36564671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
    Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
    Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the Research Domain Criteria as a framework to integrate psychophysiological findings into stress management and psychotherapy interventions.
    Steffen PR
    Front Neuroergon; 2023; 4():1245946. PubMed ID: 38234487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underlying mechanisms of disruptive mood dysregulation disorder in children: A systematic review by means of research domain criteria.
    Brænden A; Zeiner P; Coldevin M; Stubberud J; Melinder A
    JCPP Adv; 2022 Mar; 2(1):e12060. PubMed ID: 37431494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of genes on "positive valence systems" constructs: A systematic review.
    Hess JL; Kawaguchi DM; Wagner KE; Faraone SV; Glatt SJ
    Am J Med Genet B Neuropsychiatr Genet; 2016 Jan; 171B(1):92-110. PubMed ID: 26365619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.